Search Results - "Irby, Rosalyn B"
-
1
Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway
Published in Bioorganic & medicinal chemistry (15-10-2011)“…A novel series of 5,7-dibromoisatin analogs were synthesized and evaluated for their cytotoxicities against four human cancer cell lines including colon HT29,…”
Get full text
Journal Article -
2
The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer
Published in PloS one (12-03-2013)“…Phenylbutyl isoselenocyanate (ISC-4) is an Akt inhibitor with demonstrated preclinical efficacy against melanoma and colon cancer. In this study, we sought to…”
Get full text
Journal Article -
3
Epidermal growth factor receptor revisited: Prognostic marker or target for therapy?
Published in Cancer biology & therapy (01-09-2010)“…Commentary to: EGFR expression variance in paired colorectal cancer primary and metastatic tumors Nirit Yarom, Celia Marginean, Terence Moyana, Ivan…”
Get full text
Journal Article -
4
Activating SRC mutation in a subset of advanced human colon cancers
Published in Nature genetics (01-02-1999)“…The discovery of Rous sarcoma virus (RSV) led to the identification of cellular Src (c-Src), a non-receptor tyrosine kinase, which has since been implicated in…”
Get full text
Journal Article -
5
Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NFκB and microRNA network
Published in Molecular cancer (30-04-2010)“…Abstract Background Diminished expression or activity of prostate apoptosis response protein 4 (Par-4) has been demonstrated in a number of cancers, although…”
Get full text
Journal Article -
6
TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells
Published in Cancer biology & therapy (02-01-2017)“…The prostate apoptosis response protein 4 (Par-4) is a tumor-suppressor that has been shown to induce cancer-cell selective apoptosis in a variety of cancers…”
Get full text
Journal Article -
7
Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FU
Published in Cancer biology & therapy (01-10-2009)“…The prostate apoptosis response protein 4 (Par-4), a tumor suppressor, has been shown to induce apoptosis in cancer cells. While reduced Par-4 expression has…”
Get full text
Journal Article -
8
Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
Published in PloS one (07-11-2013)“…Summary of combinatorial effects of ISC-4 with approved antitumor agents. (2013) Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in…”
Get full text
Journal Article -
9
Identification of Src transformation fingerprint in human colon cancer
Published in Oncogene (17-10-2002)“…We used a classical rodent model of transformation to understand the transcriptional processes, and hence the molecular and cellular events a given cell…”
Get full text
Journal Article -
10
Iterative microarray and RNA interference-based interrogation of the Src-induced invasive phenotype
Published in Cancer research (Chicago, Ill.) (01-03-2005)“…Src kinase has long been recognized as a factor in the progression of colorectal cancer and seems to play a specific role in the development of the metastatic…”
Get full text
Journal Article -
11
Role of Src expression and activation in human cancer
Published in Oncogene (20-11-2000)“…Since the original identification of a transmissible agent responsible for the development of tumors in chickens, now known to be a retrovirus encoding the…”
Get full text
Journal Article -
12
The Akt Inhibitor ISC-4 Activates Prostate Apoptosis Response Protein-4 and Reduces Colon Tumor Growth in a Nude Mouse Model
Published in Clinical cancer research (01-07-2011)“…Prostate apoptosis response protein-4 (Par-4) sensitizes cells to chemotherapy; however, Akt1 inactivates Par-4. Previously we showed that Par-4-overexpressing…”
Get full text
Journal Article -
13
Par-4 as a potential target for cancer therapy
Published in Expert opinion on therapeutic targets (01-01-2013)“…Despite extensive research, cancer continues to be a leading cause of death worldwide and is expected to continue to rise as a result of an aging population…”
Get more information
Journal Article -
14
Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells
Published in Cancer research (Chicago, Ill.) (01-05-2002)“…Src has been implicated in the development and progression of human colon cancer. Because the capacity for tumor cells to dissociate from the primary tumor is…”
Get full text
Journal Article -
15
The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU
Published in Apoptosis (London) (01-12-2011)“…The overexpression of the pro-apoptotic protein Prostate Apoptosis Response Protein-4 in colon cancer has been shown to increase response to the…”
Get full text
Journal Article -
16
Tumor Necrosis Factor α Induces p53 Up-regulated Modulator of Apoptosis Expression in Colorectal Cancer Cell Lines
Published in Diseases of the colon & rectum (01-03-2010)“…PURPOSE:Inflammatory bowel disease (IBD)–associated colorectal carcinogenesis involves dysregulation of multiple cellular pathways, including p53 signaling and…”
Get full text
Journal Article -
17
Src kinase induces tumor formation in the c‐SRC C57BL/6 mouse
Published in International journal of cancer (15-06-2008)“…Src kinase has been linked as a causative agent in the progression of a number of cancers including colon, breast, lung and melanoma. Src protein and activity…”
Get full text
Journal Article -
18
Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression
Published in Molecular carcinogenesis (01-08-2005)“…Tumor progression is a multistep process, which enables cells to evolve from benign to malignant tumors. This progression has been suggested to depend on six…”
Get full text
Journal Article -
19
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: Results of a bone marrow failure consortium study
Published in Leukemia research (01-05-2012)“…Abstract Large granular lymphocyte (LGL) leukemia is characterized by clonal expansion of antigen-activated cytotoxic T cells (CTL). Patients frequently…”
Get full text
Journal Article -
20
Src activity alters α3 integrin expression in colon tumor cells
Published in Clinical & experimental metastasis (01-02-2009)“…Src kinase has been linked to increased motility in the progression and metastasis of human colon cancer, although the mechanisms are not fully understood…”
Get full text
Journal Article